 SAN DIEGO, Nov. 9, 2020 PRNewswire -- Biocept, Inc. NASDAQ: BIOC, a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announces that it has been awarded... 